Numinus welcomes psychedelic pioneer, Rick Doblin, Ph.D., as strategic advisor Updates market on closing of previously announced bought deal /THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT… Read More
Advancing two new preclinical programs in Alzheimer’s and Age-Related Macular Degeneration Closed calendar year 2023 with cash position of US$9.5 million 164% revenue growth in the commercial BayMedica subsidiary VANCOUVER,… Read More
VANCOUVER, BC – A new labour market intelligence study conducted by Life Sciences BC shows a critical need for more skilled talent across British Columbia’s life sciences sector. The province’s… Read More
– Over 8,000 patients 12 years of age and older with severe sickle cell disease or transfusion-dependent beta thalassemia may be eligible for treatment – LONDON, EN – Vertex Pharmaceuticals… Read More
Funding to attract and advance Canadian clinical research in inflammatory bowel disease TORONTO, ON – Takeda Canada Inc. (Takeda) is pleased to announce its support of the Canadian Inflammatory Bowel Disease… Read More
